Cover - USD ($)	12 Months Ended
Cover - USD ($)	Dec. 31, 2025	Dec. 31, 2024	Jun. 02, 2026	Jun. 30, 2025
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2025
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2025
Current Fiscal Year End Date	--12-31
Entity File Number	001-39701
Entity Registrant Name	INVO FERTILITY, INC.
Entity Central Index Key	0001417926
Entity Tax Identification Number	20-4036208
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	5582 Broadcast Court
Entity Address, City or Town	Sarasota
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	34240
City Area Code	(978)
Local Phone Number	878-9505
Title of 12(b) Security	Common Stock, $0.0001 par value per share
Trading Symbol	IVF
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float				$ 2,185,985
Entity Common Stock, Shares Outstanding			1,786,035
Documents Incorporated by Reference [Text Block]	None.
ICFR Auditor Attestation Flag	false
Document Financial Statement Error Correction [Flag]	true
Document Financial Statement Restatement Recovery Analysis [Flag]	false
Entity Listing, Par Value Per Share	$ 0.0001
Auditor Firm ID	100	2738
Auditor Opinion [Text Block]	We have audited the accompanying consolidated balance sheet of INVO Fertility, Inc. (the “Company”) as of December 31, 2025, and the related consolidated statements of operations, of Stockholders’ Equity and Mezzanine Equity, and of cash flows for year ended December 31, 2025, and the related notes to the consolidated financial statements (collectively referred to as the “consolidated financial statements”). In our opinion, the financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2025, and the results of its operations and its cash flows for the year ended December 31, 2025, in conformity with accounting principles generally accepted in the United States of America. We also have audited the adjustments described in Note 1 that were applied to the recast of the December 31, 2024 consolidated balance sheet, consolidated statement of operations, and cash flows in relation to discontinued operations. In our opinion, such adjustments are appropriate and have been properly applied. We were not engaged to audit, review, or apply any procedures to the 2024 consolidated financial statements of the Company, other than with respect to the adjustment and, accordingly, we do not express an opinion or any other form of assurance on the 2024 consolidated financial statements taken as a whole.
Auditor Name	WithumSmith+Brown, PC	M&K CPAS, PLLC
Auditor Location	Irvine, CA	The Woodlands, TX

INVO Fertility, Inc. 10-K